Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

30.92
BATS BZX Real-Time Price
As of 10:30am ET
 -0.21 / -0.67%
Today’s Change
26.97
Today|||52-Week Range
34.88
-8.92%
Year-to-Date
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
Valeant/Progenics Relistor Ok'd; FDA Panel Backs Brodalumab
Jul 20 / Zacks.com - Paid Partner Content
European Stock Markets Mixed After Signs of Brexit Damage
Jul 22 / TheStreet.com - Paid Partner Content
AstraZeneca's (AZN) Tagrisso Hits Phase III Primary Endpoint
Jul 19 / Zacks.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Valeant's (VRX) Brodalumab BLA Up for Review in the U.S.
Jul 18 / Zacks.com - Paid Partner Content
Why Shares of Relypsa Are Soaring Today
Jul 21 / MotleyFool.com - Paid Partner Content
Is This Gilead Sciences' Most Underappreciated Drug Candidate?
Jul 18 / MotleyFool.com - Paid Partner Content
Relypsa Finally Finds Buyer, But Potential Seen For Rival Bid
Jul 21 / TheStreet.com - Paid Partner Content
Is Advaxis' Stock Now a Bargain?
Jul 15 / MotleyFool.com - Paid Partner Content
Heavy Volume And Pre-Market Movement For AstraZeneca (AZN)
Jul 21 / TheStreet.com - Paid Partner Content
3 Dividend Aristocrats to Avoid
Jul 14 / MotleyFool.com - Paid Partner Content
AstraZeneca (AZN) Is Today's Storm The Castle Stock
Jul 20 / TheStreet.com - Paid Partner Content
Why Inovio Pharmaceuticals' Stock Plunged in June
Jul 14 / MotleyFool.com - Paid Partner Content